Age-adjusted prevalence of sexually transmitted infections in the pre-MDA and post-MDA surveys
| Post-MDA survey % (95% CI) | ||||
|---|---|---|---|---|
| Pre-MDA survey | Overall | Reported receiving treatment during MDA | Reported not receiving treatment during MDA | |
| Chlamydia trachomatis | 20.7% (12.8% to 29.9%) | 12.5% (7.7% to 21.4%) | 10.6% (4.3% to 25.2%) | 14.8% (8.5% to 28.7%) |
| Neisseria gonorrhoeae | 5.2% (1.8% to 12.1%) | 3.1% (0.8% to 10.0%) | 1.1% (1.3% to 18.5%) | 5.4% (0.3% to 11.4%) |
MDA, mass drug administration.